Subscribe To
Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...
November 20, 2022, 6:30 pm
Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...
November 20, 2022, 6:30 pm
Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...
November 20, 2022, 6:30 pm
Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...
November 20, 2022, 6:30 pm
Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...
November 20, 2022, 6:30 pm
Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...
November 20, 2022, 6:30 pm
Gold miners’ q3’22 fundamentals
The major gold miners just reported a weaker quarter. Their collective production fell despite overall ...
November 19, 2022, 8:01 am
Copper is the simplest investment thesis anywhere
The best investments are often the simplest ideas. This chart from Goldman Sachs represents the single, most-compelling long-term investment that I...
November 18, 2022, 2:14 pm
Rosen, leading investor counsel, encourages tusimple holdings, inc. investors with losses to secure counsel before important deadline in first filed securities class action initiated by the firm – tsp
NEW YORK, Nov. 16, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on ...
November 17, 2022, 12:38 am
Membership collective group (mcg) reports q3 loss, lags revenue estimates
Membership collective (MCG) delivered earnings and revenue surprises of -360% and 1.88%, respectively, ...
November 16, 2022, 10:32 am
Membership collective group inc. (mcg) q3 2022 earnings call transcript
Membership collective Group Inc. (NYSE:MCG ) Q3 2022 Earnings Conference Call November 16, 2022 9:00 AM...
November 16, 2022, 9:53 am
Avantis investors cio eduardo repetto talks building the brand over 3 years
Avantis Investors, an investment offering from global asset manager American Century Investments, recently reached the three-year anniversary of bring...
November 14, 2022, 4:28 pm
Rosen, global investor counsel, encourages tusimple holdings, inc. investors to secure counsel before important deadline in first filed securities class action commenced by the firm – tsp
NEW YORK, Nov. 12, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on ...
November 12, 2022, 9:53 pm
My 11 best dividend kings for november 2022
The 48 Dividend Kings finished October with a nice gain, collectively up 10.85%. Last month, the 11 bes...
November 8, 2022, 5:51 am
Nike: undersold on solid fundamentals and low downside risk
Although NIKE's value proposition, fundamentals, and downside risks collectively present a global brand...
September 9, 2022, 6:09 pm
An army of tesla fans in south korea holds a collective stake of more than $15 billion in elon musk's company, putting them among its top shareholders, report says
One family in South Korea ploughed their entire $230,000 life savings into Tesla stock, Bloomberg reported....
August 24, 2022, 7:03 am
Tiktok stars boycott amazon in activism push
TikTok influencers boasting collectively more than 51 million followers say they won't work with Amazon...
August 24, 2022, 4:04 am
U.s. lawmakers unveil bill to help news media negotiate with google, facebook
A bipartisan group of U.S. lawmakers on Monday released a revised version of a bill aimed at making it easier for news organizations to negotiate
August 22, 2022, 7:57 pm
Empower clinics says it will divest two tmc clinics following operational review
Empower Clinics Inc. (CSE:CBDT, OTCQB:EPWCF) has said that following an operational review it will divest two clinics, located in Hamilton and Missi...
August 22, 2022, 7:38 am
Factbox-big banks expected to rack up more than $1 billion in fines for whatsapp use
Banking giants such as JPMorgan Chase & Co and Bank of America collectively face more than $1 billion i...
August 22, 2022, 6:18 am